Success Metrics

Clinical Success Rate
100.0%

Based on 13 completed trials

Completion Rate
100%(13/13)
Active Trials
4(21%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
5%
Ph phase_4
1
5%
Ph phase_2
2
11%
Ph not_applicable
14
74%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution18 total trials
Phase 1Safety & dosage
1(5.6%)
Phase 2Efficacy & side effects
2(11.1%)
Phase 4Post-market surveillance
1(5.6%)
N/ANon-phased studies
14(77.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

13 of 13 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

19

all time

Status Distribution
Active(4)
Completed(13)
Other(2)

Detailed Status

Completed13
Recruiting2
Active, not recruiting2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
19
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.6%)
Phase 22 (11.1%)
Phase 41 (5.6%)
N/A14 (77.8%)

Trials by Status

completed1368%
recruiting211%
active_not_recruiting211%
unknown211%

Recent Activity

Clinical Trials (19)

Showing 19 of 19 trials
NCT06027567Phase 4

The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure

Completed
NCT06881485Not Applicable

Naltrexone/Bupropion With or Without Very Low Calorie Ketogenic Diet for Weight Regain After Bariatric Surgery

Recruiting
NCT06363747Phase 2

The Medically Reproducing Bariatric Surgery (MRB) II Study

Active Not Recruiting
NCT02386917Not Applicable

Impact of Body Weight and Weight Loss on Drug Bioavailability, Cardiovascular Risk Factors and Metabolic Biomarkers

Active Not Recruiting
NCT06183034Not Applicable

Acceptability and Feasibility of a Preoperative Very Low Calorie Diet Intervention on Surgical Weight Loss Outcomes (SAFETY)

Unknown
NCT04957589Not Applicable

VLCD & Adjuvant Exercise Effect in Overweight Diabetic Men

Completed
NCT05055154Not Applicable

Oxidative Stress and L-CBMN Cytome Assay in Obese After 3 Weeks VLCD

Completed
NCT05007171Not Applicable

Changes in Anthropometric, Biochemical and DNA Damage Parameters After 3-weeks VLCD in Severely Obese Patients

Completed
NCT01945840Not Applicable

Gut Hormones and Roux en Y Gastric Bypass

Recruiting
NCT03553849Not Applicable

Utilization of Very Low Calorie Diet in Obese General Surgery Patients

Completed
NCT02070770Not Applicable

The Effect of a Short-term Very Low Calorie Diet on Heart Rate Variability in Obese Individuals

Completed
NCT00627484

Changes in Insulin Sensitivity After Weight Loss

Completed
NCT01474785Phase 1

RYGB and the Gastric Adipose Axis

Completed
NCT02251574Not Applicable

Effect of a Very Low Calorie and Low Calorie Diet on Moderate to Severe Obstructive Sleep Apnea in Obese Adults

Completed
NCT03132662Not Applicable

Omega-3 vs Very Low Calorie Diet for Liver Size Reduction

Unknown
NCT03102372Not Applicable

Preservation of Fat Free Mass During Weight Loss

Completed
NCT01671969Not Applicable

Very Low Calorie Diet for Diabetic Kidney Disease

Completed
NCT01447524Not Applicable

Caloric Restriction and Insulin Secretion

Completed
NCT00050791Phase 2

Effects of Leptin Treatment on Weight Loss

Completed

All 19 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
19